Importance of Payer/Clinician Agreement in Patient Treatment

Multiple sclerosis can profoundly affect the lives of those who receive the diagnosis, and racial and ethnic minorities appear to experience unique challenges regarding disease characteristics and access to care. Among these groups, the disease course may be more active (14) and the MS manifestations more severe. (12) For Black patients, certain DMTs may be less effective. (22) Sometimes experiencing barriers to care related to health literacy, income or health insurance coverage, (10) these groups may benefit from increased management across the care continuum that ensures access to patient education, financial and other support resources, and treatment tailored to their unique disease course.